会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 7. 发明授权
    • Method of detecting bladder cancer
    • 检测膀胱癌的方法
    • US08999296B2
    • 2015-04-07
    • US12988621
    • 2009-04-21
    • Keiji InoueMasahiro IshizukaTohru Tanaka
    • Keiji InoueMasahiro IshizukaTohru Tanaka
    • A61K49/00A61K31/198A61K41/00
    • A61K49/0021A61K41/0061Y10S514/814
    • Provided is a sensitizing detection agent of an oral or intravenous administration type which enables the detection of bladder cancer with a higher sensitivity without causing pain to the patient. A sensitizing detection agent for bladder cancer comprising 5-aminolevulinic acid (ALA), a derivative thereof, or a salt of these is orally or intravenously administered, and a video camera system is inserted via the urethra and a blue light at 380-440 nm is irradiated to observe the red fluorescent part. Further, VLD-M1 is inserted and a blue light at 405 nm is irradiated to observe fluorescence intensity (relative intensity) of the red light part. For oral administration, 20 mg/kg (maximum of 1 g) of ALA is dissolved in 50 mL of a 5% glucose solution prior to the administration.
    • 本发明提供口服或静脉内给药型敏化检测剂,其能够以更高的灵敏度检测膀胱癌,而不会对患者造成疼痛。 通过口服或静脉内施用包含5-氨基乙酰丙酸(ALA),其衍生物或其盐的膀胱癌敏化检测剂,通过尿道插入摄像机系统,并将380-440nm的蓝光 照射以观察红色荧光部分。 此外,插入VLD-M1,照射405nm的蓝色光,以观察红色光部分的荧光强度(相对强度)。 对于口服给药,在施用前将20mg / kg(最多1g)的ALA溶于50mL的5%葡萄糖溶液中。